Bio-Techne Corporation is a biotech company developing new medicines.
Bio-Techne Corporation (TECH) is expected to report earnings on Wednesday, November 4, 2026, after the close. Estimated release time 06:30 ET. Consensus EPS estimate is $0.46.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-12 | FY2026 Q2 | $0.52 | $0.52 | +0.2% | $321.19M |
| 2026-05-06 | FY2026 Q1 | $0.55 | $0.53 | -3.6% | $311.42M |
| 2026-02-04 | FY2025 Q4 | $0.43 | $0.46 | +7.0% | $295.88M |
| 2025-11-05 | FY2025 Q3 | $0.42 | $0.36 | -14.6% | $286.56M |
| 2025-08-06 | FY2025 Q2 | — | $-0.11 | — | $316.96M |
| 2025-05-08 | FY2025 Q1 | $0.51 | $0.56 | +10.2% | $316.18M |
| 2025-02-06 | FY2024 Q4 | $0.39 | $0.42 | +8.8% | $297.03M |
| 2024-10-30 | FY2024 Q3 | $0.38 | $0.42 | +10.5% | $289.46M |
TECH has beaten consensus EPS in 5 of its last 8 reported quarters.
Highlights from TECH's Aug 12 report: EPS of $0.52 — in line with the $0.52 estimate; revenue of $321M — a beat vs the $315M consensus (+2%).
TECH pays a irregular dividend, currently yielding 0.44%.
| Ex-dividend date | Amount | Paid |
|---|---|---|
| 2026-08-24 | $0.08 | 2026-09-04 |
| 2026-08-24 | $0.08 | 2026-09-04 |
| 2026-05-18 | $0.08 | 2026-05-29 |
| 2026-02-13 | $0.08 | 2026-02-27 |
| 2025-11-17 | $0.08 | 2025-11-28 |
| 2025-08-18 | $0.08 | 2025-08-29 |